Clinical trialNCT05310448RecruitingInterventional

Tumor Treating Fields for the Treatment of Brainstem Gliomas

SponsorEmory UniversityEnrollment10Glioma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-intensity, wave-like electric fields called tumor treating fields (TTFields), which interfere with cancer cell division. TTFields may prevent growth or decrease size of gliomas in patients

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Jim Zhong, MD
Emory University Hospital/Winship Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Emory Proton Therapy Center
Atlanta, Georgia, United States
Jim Zhong, MD
Not, yet, recruiting
Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
Jim Zhong, MD
Not, yet, recruiting
Emory University/winship Cancer Institute
Atlanta, Georgia, United States
Jim Zhong, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 May 2022
Primary completion: 1 Sept 2027
Completion: 1 May 2028
Last update posted: 19 Oct 2026
Registered enrollment: 10
Registry id: NCT05310448

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.